Supplementary Figure 5 from A p53/ARF-Dependent Anticancer Barrier Activates Senescence and Blocks Tumorigenesis without Impacting Apoptosis
Year: 2023
Type: supplementary-materials
Abstract: Loss of p53 does not diminish DDR following ErbB2 activation.
Authors: Vidya C. Sinha, Lan Qin, Yi Li
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362536934